CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate particularities and quality of medical antihypertensive therapy in hypertensive patients in real outpatient practice with a help of the Registry in Ryazan region.Material and methods. A total of 3690 patients with...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1186 |
| _version_ | 1797232242181799936 |
|---|---|
| author | M. M. Loukianov S. A. Boytsov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelnyy N. N. Nikulina K. G. Pereverzeva E. A. Pravkina A. D. Deev E. V. Kudryashov E. N. Belova |
| author_facet | M. M. Loukianov S. A. Boytsov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelnyy N. N. Nikulina K. G. Pereverzeva E. A. Pravkina A. D. Deev E. V. Kudryashov E. N. Belova |
| author_sort | M. M. Loukianov |
| collection | DOAJ |
| description | Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate particularities and quality of medical antihypertensive therapy in hypertensive patients in real outpatient practice with a help of the Registry in Ryazan region.Material and methods. A total of 3690 patients with hypertension, ischemic heart disease, chronic heart failure and atrial fibrillation, who had attended general practitioners and cardiologists of 3 outpatient clinics in Ryazan city, were enrolled in the outpatient Registry of cardiovascular diseases (RECVASA). The diagnosis of hypertension was recorded in 3648 of 3690 (98.9%) outpatient charts, 28.1% of the subjects were men and 71.9% - women.Results. A total of 2907 (79.7%) of 3648 patients had combination of hypertension with other CVDs. Combination of 3-4 cardiovascular diagnoses was registered in 63.8% of the cases. 11.5% and 9.5% of the patients had a history of myocardial infarction and cerebral stroke, respectively. Diagnosis of hypertension was verified in 448 of 450 randomized hypertensive patients (99.6%). The incidence of prescription of one and two antihypertensive drugs (AHDs) was 25% and 39%, respectively, of 3 AHDs – 21%, 4 and more – 2%. AHDs were not prescribed in 13% of hypertensive patients. The mean number of prescribed AHDs was 1.73. The mean incidence rate of target blood pressure achievement was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta-blockers prescription in different concomitant CVDs. Patients with 3-4 cardiovascular diagnoses were more often prescribed combined antihypertensive treatment. Prescription of ACE inhibitors/ARB, beta-blockers and thiazide diuretics combination was preferable in 74.1% of the cases, when taking into account absolute and relative contraindications for betablockers use – in 64.0%. 15.2% of the hypertensive patients used reimbursed drugs for CVDs at the moment of the Registry enrollment as compared with 39.2% in previous years (p<0.05).Conclusion. The RECVASA study data allowed revealing high incidence of concomitant CVDs in hypertensive patients, insufficient use of combined antihypertensive treatment, including AHDs with proved favorable influence on prognosis. Achievement of concordance of medical treatment to national and international guidelines, taking into account concomitant CVDs, and optimization of patients’ coverage with reimbursed drugs are the main reserves for antihypertensive treatment quality improvement. |
| first_indexed | 2024-03-08T14:03:17Z |
| format | Article |
| id | doaj.art-9a5f2903374b4d5d851271d19e2eaf52 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:57:09Z |
| publishDate | 2016-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-9a5f2903374b4d5d851271d19e2eaf522024-04-01T07:43:33ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-03-0112141510.20996/1819-6446-2016-12-1-4-151175CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)M. M. Loukianov0S. A. Boytsov1S. S. Yakushin2S. Yu. Martsevich3A. N. Vorobyev4A. V. Zagrebelnyy5N. N. Nikulina6K. G. Pereverzeva7E. A. Pravkina8A. D. Deev9E. V. Kudryashov10E. N. Belova11State Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaRyazan State Medical University named after academician I.P. Pavlov Visokovoltnaya ul. 9, Ryazan, 390026 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaRyazan State Medical University named after academician I.P. Pavlov Visokovoltnaya ul. 9, Ryazan, 390026 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaRyazan State Medical University named after academician I.P. Pavlov Visokovoltnaya ul. 9, Ryazan, 390026 RussiaRyazan State Medical University named after academician I.P. Pavlov Visokovoltnaya ul. 9, Ryazan, 390026 RussiaRyazan State Medical University named after academician I.P. Pavlov Visokovoltnaya ul. 9, Ryazan, 390026 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaState Scientific Research Center for Preventive Medicine Petroverigsky per. 10, Moscow, 101990 RussiaAim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate particularities and quality of medical antihypertensive therapy in hypertensive patients in real outpatient practice with a help of the Registry in Ryazan region.Material and methods. A total of 3690 patients with hypertension, ischemic heart disease, chronic heart failure and atrial fibrillation, who had attended general practitioners and cardiologists of 3 outpatient clinics in Ryazan city, were enrolled in the outpatient Registry of cardiovascular diseases (RECVASA). The diagnosis of hypertension was recorded in 3648 of 3690 (98.9%) outpatient charts, 28.1% of the subjects were men and 71.9% - women.Results. A total of 2907 (79.7%) of 3648 patients had combination of hypertension with other CVDs. Combination of 3-4 cardiovascular diagnoses was registered in 63.8% of the cases. 11.5% and 9.5% of the patients had a history of myocardial infarction and cerebral stroke, respectively. Diagnosis of hypertension was verified in 448 of 450 randomized hypertensive patients (99.6%). The incidence of prescription of one and two antihypertensive drugs (AHDs) was 25% and 39%, respectively, of 3 AHDs – 21%, 4 and more – 2%. AHDs were not prescribed in 13% of hypertensive patients. The mean number of prescribed AHDs was 1.73. The mean incidence rate of target blood pressure achievement was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta-blockers prescription in different concomitant CVDs. Patients with 3-4 cardiovascular diagnoses were more often prescribed combined antihypertensive treatment. Prescription of ACE inhibitors/ARB, beta-blockers and thiazide diuretics combination was preferable in 74.1% of the cases, when taking into account absolute and relative contraindications for betablockers use – in 64.0%. 15.2% of the hypertensive patients used reimbursed drugs for CVDs at the moment of the Registry enrollment as compared with 39.2% in previous years (p<0.05).Conclusion. The RECVASA study data allowed revealing high incidence of concomitant CVDs in hypertensive patients, insufficient use of combined antihypertensive treatment, including AHDs with proved favorable influence on prognosis. Achievement of concordance of medical treatment to national and international guidelines, taking into account concomitant CVDs, and optimization of patients’ coverage with reimbursed drugs are the main reserves for antihypertensive treatment quality improvement.https://www.rpcardio.online/jour/article/view/1186registryarterial hypertensioncardiovascular diseasecombined antihypertensive treatmenttreatment quality assessmentoutpatient practiceconcomitant cardiovascular pathologyconcomitant indications for medical treatmenttarget blood pressure level |
| spellingShingle | M. M. Loukianov S. A. Boytsov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelnyy N. N. Nikulina K. G. Pereverzeva E. A. Pravkina A. D. Deev E. V. Kudryashov E. N. Belova CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Рациональная фармакотерапия в кардиологии registry arterial hypertension cardiovascular disease combined antihypertensive treatment treatment quality assessment outpatient practice concomitant cardiovascular pathology concomitant indications for medical treatment target blood pressure level |
| title | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) |
| title_full | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) |
| title_fullStr | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) |
| title_full_unstemmed | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) |
| title_short | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) |
| title_sort | concomitant cardiovascular diseases and antihypertensive treatment in outpatient practice by the recvasa registry data |
| topic | registry arterial hypertension cardiovascular disease combined antihypertensive treatment treatment quality assessment outpatient practice concomitant cardiovascular pathology concomitant indications for medical treatment target blood pressure level |
| url | https://www.rpcardio.online/jour/article/view/1186 |
| work_keys_str_mv | AT mmloukianov concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT saboytsov concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT ssyakushin concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT syumartsevich concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT anvorobyev concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT avzagrebelnyy concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT nnnikulina concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT kgpereverzeva concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT eapravkina concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT addeev concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT evkudryashov concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata AT enbelova concomitantcardiovasculardiseasesandantihypertensivetreatmentinoutpatientpracticebytherecvasaregistrydata |